Literature DB >> 19136108

Metallic stents for gastric outlet obstruction: reintervention rate is lower with uncovered versus covered stents, despite similar outcomes.

Iruru Maetani1, Takeo Ukita, Tomoko Tada, Hiroaki Shigoka, Shigefumi Omuta, Takuro Endo.   

Abstract

BACKGROUND: Self-expandable metallic stents (SEMSs) are widely used for palliation of malignant gastric outlet obstruction (GOO). A common complication of their use, however, is stent obstruction caused by tumor ingrowth or hyperplasia. The covered SEMS was designed to prevent these problems.
OBJECTIVE: We compared the performance of uncovered and covered SEMSs in patients with GOO.
DESIGN: A retrospective study, single center.
SETTING: A tertiary-referral center. PATIENTS: Sixty patients with symptomatic malignant GOO.
INTERVENTIONS: All patients received an uncovered or covered knitted nitinol stent by using the over-the-wire placement procedure. MAIN OUTCOME MEASUREMENT: Comparison of the clinical outcome, complications, and the reintervention rate between uncovered and covered stents.
RESULTS: Thirty-one patients (mean [+/-SEM] age 72.2 +/- 2.1 years; 16 men) received uncovered SEMSs, and 29 (mean [+/-SEM] age 70.6 +/- 1.7 years; 17 men) received covered SEMSs. The technical success rate was 100% in both groups. No difference in clinical success was seen (90.3% uncovered group vs 86.2% covered group). Regarding early complications (<1 week), one mild case of pancreatitis from the stent covering the papilla occurred in each group. Late complications included reobstruction, migration, bleeding, stent fracture, and perforation. The occurrence of reobstruction did not differ between the 2 groups (3.2% uncovered group vs 10.3% covered group). No difference in migration (0% uncovered group vs 6.9% covered group) was seen. The uncovered group required less frequent reinterventions for stent reobstruction, migration, or stent fracture (3.2% uncovered group vs 20.7% covered group, P = .0490). The uncovered group had 2 major late complications: bleeding and perforation. All 60 patients died, with a median survival time of 51 days and 62 days, respectively. LIMITATIONS: Small-sized, single-center, retrospective study.
CONCLUSIONS: In palliation for malignant GOO, covered stents were associated with a more frequent need for reintervention than uncovered stents, despite similar outcomes and complications. These results require confirmation in a larger randomized comparison.

Entities:  

Mesh:

Year:  2009        PMID: 19136108     DOI: 10.1016/j.gie.2008.06.009

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  21 in total

1.  Duodenal and colonic stent placement with 0.025″ and 0.035″ guidewires is equally safe and effective.

Authors:  Jessica Chan; Kristen Hilden; John Fang; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

2.  Outcomes of second self-expandable metallic stent insertion for malignant gastric outlet obstruction.

Authors:  Chan Gyoo Kim; Il Ju Choi; Jong Yeul Lee; Soo-Jeong Cho; Soo Jin Kim; Mi-Jung Kim; Sook Ryun Park; Young Lee Park
Journal:  Surg Endosc       Date:  2013-09-12       Impact factor: 4.584

3.  Clinical outcomes of re-stenting in patients with stent malfunction in malignant gastric outlet obstruction.

Authors:  Eun Hyo Jin; Sang Gyun Kim; Ji Yeon Seo; Jong Pil Im; Joo Sung Kim; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2015-07-03       Impact factor: 4.584

4.  Winged Partially Covered Self-Expandable Metal Stent to Prevent Distal Migration in Malignant Gastric Outlet Obstruction.

Authors:  Young Kwon Choi; Ji Yong Ahn; Hee Kyong Na; Kee Wook Jung; Do Hoon Kim; Jeong Hoon Lee; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung
Journal:  Dig Dis Sci       Date:  2018-09-19       Impact factor: 3.199

5.  Outcomes of endoscopically inserted self-expandable metal stents in malignancy according to the type of stent and the site of obstruction.

Authors:  Kyoungwon Jung; Ji Yong Ahn; Hwoon-Yong Jung; Charles J Cho; Hee Kyong Na; Kee Wook Jung; Jeong Hoon Lee; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Jin-Ho Kim
Journal:  Surg Endosc       Date:  2015-12-29       Impact factor: 4.584

6.  A double-layered (comvi) self-expandable metal stent for malignant gastroduodenal obstruction: a prospective multicenter study.

Authors:  Yong Wuk Kim; Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Chung Uk Chung; Dong Uk Kim; Su Bum Park; Kee Tae Park; Suk Kim; Eul Jo Jeung; Yong Mok Bae
Journal:  Dig Dis Sci       Date:  2011-01-25       Impact factor: 3.199

7.  Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariate.

Authors:  Tsuyoshi Hamada; Yousuke Nakai; Hiroyuki Isayama; Takashi Sasaki; Hirofumi Kogure; Kazumichi Kawakubo; Naoki Sasahira; Natsuyo Yamamoto; Osamu Togawa; Suguru Mizuno; Yukiko Ito; Kenji Hirano; Nobuo Toda; Minoru Tada; Kazuhiko Koike
Journal:  Surg Endosc       Date:  2012-10-17       Impact factor: 4.584

Review 8.  Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents.

Authors:  Jill K J Gaidos; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

9.  Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer.

Authors:  Sang Myung Woo; Dong Hwan Kim; Woo Jin Lee; Kyung Woo Park; Sang-Jae Park; Sung-Sik Han; Tae Hyun Kim; Young Hwan Koh; Hyun Bum Kim; Eun Kyung Hong
Journal:  Surg Endosc       Date:  2013-01-04       Impact factor: 4.584

10.  An instant rare complication: a fractured metallic pyloric stent.

Authors:  Mahvesh Rana Javaid; Aasim Mohammad Yusuf
Journal:  BMJ Case Rep       Date:  2013-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.